Trial intelligence / Profile preview

Randomized Comparisons of Oral Mercaptopurine vs Oral Thioguanine and IT Methotrexate vs ITT for Standard Risk Acute Lymphoblastic Leukemia

NCT00002744Phase 3Completed

Sponsor
Children's Oncology Group
Start
May 1996
Primary completion
Mar 2007
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of tioguanine, cytarabine, hydrocortisone in acute lymphoblastic leukemia (ALL), sponsored by Children's Oncology Group. Started May 1996; status: completed.

02

Drugs

tioguaninecytarabinehydrocortisone
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on NCT00002744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call